La cadena de opciones muestra datos clave de las opciones de acciones de Avinger a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Avinger..

Avinger (NASDAQ:AVGR) Bolsa, Cadena de Opciones

Avinger

Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AEHR

ATCH

ATPC

AVGR

CANG

CHCI

HCWC

LIDR

NMHI

PHIO

PIII

RGNX

RIME

SANG

STAF

URGN

YOSH

Las acciones de KB Home suben 9,1% tras superar expectativas de ganancias. Descubre los mayores ganadores y perdedores del mercado hoy.

Las acciones de KB Home se disparan un 9%; 20 acciones que se mueven en el premercado de EE.UU.

AMPG

BIPC

CHEK

CREV

FDSB

HSDT

KORE

LAES

LIND

NCRA

NEUE

NVNI

RELI

SLGL

TIVC

TLRY

TOVX

Carbon Revolution lidera con un aumento del 62,4% en el premercado. ¿Qué otras acciones destacaron antes de la apertura?

Las acciones de Carbon Revolution (CREV) están subiendo un 62%; 20 acciones que se están moviendo en el premercado

Avinger Inc

<h3>Gainers</h3>
<ul>
<li>Firefly Neuroscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIFF#NASDAQ">AIFF</a>) shares increased by 134.7% to $4.46 during Tuesday's pre-market session. The company's market cap stands at $37.9 million. </li>
<li>Eterna Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERNA#NASDAQ">ERNA</a>) shares increased by 65.04% to $0.51. The market value of their outstanding shares is at $26.2 million. </li>
<li>P3 Health Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIII#NASDAQ">PIII</a>) shares moved upwards by 30.29% to $0.28. The company's market cap stands at $45.6 million. </li>
<li>Nexalin Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXL#NASDAQ">NXL</a>) stock increased by 18.72% to $2.98. The company's market cap stands at $39.6 million. </li>
<li>Portage Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) stock rose 17.56% to $5.02. The market value of their outstanding shares is at $5.6 million. </li>
<li>Vaxart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VXRT#NASDAQ">VXRT</a>) stock moved upwards by 15.94% to $0.83. The market value of their outstanding shares is at $189.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Phio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) stock decreased by 41.8% to $3.84 during Tuesday's pre-market session. The company's market cap stands at $6.6 million. </li>
<li>Agape ATP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) shares declined by 25.89% to $1.46. The company's market cap stands at $5.8 million. </li>
<li>Avinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) shares decreased by 23.23% to $0.62. The company's market cap stands at $1.9 million. </li>
<li>Salarius Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRX#NASDAQ">SLRX</a>) shares decreased by 17.99% to $3.01. The company's market cap stands at $4.3 million. </li>
<li>QuidelOrtho (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QDEL#NASDAQ">QDEL</a>) stock decreased by 16.5% to $37.25. The company's market cap stands at $2.5 billion. </li>
<li>Kairos Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KAPA#AMEX">KAPA</a>) shares decreased by 15.5% to $1.8. The market value of their outstanding shares is at $23.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIFF

ERNA

KAPA

PRTG

QDEL

SLRX

VXRT

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>P3 Health Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIII#NASDAQ">PIII</a>) shares increased by 43.8% to $0.31 during Tuesday's pre-market session. The company's market cap stands at $50.3 million. </li>
<li>Immuron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMRN#NASDAQ">IMRN</a>) stock increased by 22.33% to $2.41. The market value of their outstanding shares is at $13.7 million. </li>
<li>Co-Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CODX#NASDAQ">CODX</a>) shares rose 21.12% to $0.92. The market value of their outstanding shares is at $29.4 million. </li>
<li>Regenxbio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGNX#NASDAQ">RGNX</a>) stock rose 17.26% to $8.15. The company's market cap stands at $403.7 million. </li>
<li>Atara Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRA#NASDAQ">ATRA</a>) stock rose 15.44% to $18.69. The market value of their outstanding shares is at $107.6 million. </li>
<li>Abpro Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABP#NASDAQ">ABP</a>) stock increased by 12.3% to $1.46. The market value of their outstanding shares is at $75.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Phio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) shares declined by 42.7% to $3.78 during Tuesday's pre-market session. The company's market cap stands at $6.5 million. </li>
<li>Avinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) shares fell 21.56% to $0.63. The company's market cap stands at $2.0 million. </li>
<li>Agape ATP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) shares fell 21.32% to $1.55. The company's market cap stands at $6.1 million. </li>
<li>Salarius Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRX#NASDAQ">SLRX</a>) stock decreased by 21.26% to $2.89. The market value of their outstanding shares is at $4.1 million. </li>
<li>Anitra (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#AMEX">AZTR</a>) shares decreased by 14.8% to $0.49. The market value of their outstanding shares is at $3.7 million. </li>
<li>GT Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTBP#NASDAQ">GTBP</a>) shares decreased by 12.98% to $2.08. The market value of their outstanding shares is at $4.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATRA

AZTR

CODX

GTBP

IMRN

Shares of KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) rose sharply in today's pre-market trading after the company posted <a href="https://www.benzinga.com/news/earnings/25/01/42962366/kb-home-q4-earnings-revenue-beat-eps-beat-home-deliveries-up-17-net-orders-soar-and-more">better-than-expected fourth-quarter financial results.</a>
KB Home reported fourth-quarter revenue of $2 billion, beating analyst estimates of $1.99 billion. The U.S. homebuilder reported fourth-quarter earnings of $2.52 per share, beating analyst estimates of $2.39 per share, according to Benzinga Pro.
KB Home shares jumped 9.1% to $69.90 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Nature&#8217;s Miracle Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMHI#NASDAQ">NMHI</a>) gained 109.7% to $2.37 in pre-market trading. On Monday, Nature&#8217;s Miracle Holding announced up to $29.7 million financing.</li>
<li>Staffing 360 Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAF#NASDAQ">STAF</a>) gained 82.8% to $4.15 in pre-market trading.</li>
<li>P3 Health Partners Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIII#NASDAQ">PIII</a>) gained 35% to $0.29 in pre-market trading.</li>
<li>UroGen Pharma Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URGN#NASDAQ">URGN</a>) rose 26.6% to $12.89 in pre-market trading.</li>
<li>REGENXBIO Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGNX#NASDAQ">RGNX</a>) rose 21.7% to $8.46 in pre-market trading. REGENXBIO and Nippon Shinyaku disclosed exclusive partnership to develop and commercialize RGX-121 and RGX-111 for MPS diseases.</li>
<li>Yoshiharu Global Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YOSH#NASDAQ">YOSH</a>) gained 20.2% to $3.39 in pre-market trading. Yoshiharu secures up to $11 million in flexible financing for expansion efforts.</li>
<li>AEye, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) gained 19.2% to $1.55 in pre-market trading after dipping 33% on Monday.</li>
<li>Cango Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CANG#NYSE">CANG</a>) gained 12.3% to $4.79 in pre-market trading after declining 9% on Monday. Cango recently announced a boost in its Bitcoin mining production.</li>
<li>AtlasClear Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATCH#NASDAQ">ATCH</a>) gained 9.4% to $8.18 in pre-market trading following a 5% decline on Monday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Sangoma Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANG#NASDAQ">SANG</a>) fell 40.8% to $4.20 in pre-market trading after declining 3% on Monday.</li>
<li>Comstock Holding Companies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHCI#NASDAQ">CHCI</a>) fell 33.8% to $5.20 in today's pre-market trading. The company announced 3 new leases at Loudoun Station.</li>
<li>Agape ATP Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) shares fell 24.8% to $1.48 in pre-market trading after jumping 56% on Monday.</li>
<li>Healthy Choice Wellness Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCWC#NYSE">HCWC</a>) fell 23.8% to $1.28 in pre-market trading after dipping around 9% on Monday.</li>
<li>SMX (Security Matters) Public Limited Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NYSE">SMX</a>) shares dipped 23.5% to $0.1989 in pre-market trading. SMX shares dipped 35% on Monday after the company announced a 28.5-for-1 reverse stock split.</li>
<li>Avinger, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) fell 21.4% to $0.6316 in pre-market trading. Avinger shares jumped 43% on Monday after the company announced it has been granted European patent number EP3322338 titled &#8220;MICRO-MOLDED ANAMORPHIC REFLECTOR LENS FOR IMAGE GUIDED THERAPEUTIC/DIAGNOSTIC CATHETERS&#8221;.</li>
<li>Algorhythm Holdings, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIME#NASDAQ">RIME</a>) dipped 20.5% to $0.0798 in pre-market trading following a 25% decline on Monday.</li>
<li>Phio Pharmaceuticals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) shares fell 20.5% to $5.25 in pre-market trading. Phio Pharmaceuticals shares jumped over 290% on Monday after the company reported a 100% tumor clearance in two patients in its PH-762 Phase 1b cancer study.</li>
<li>Aehr Test Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) declined 19.3% to $12.90 in pre-market trading after the company reported worse-than-expected financial results for the second quarter on Monday.</li>
<li>FTAI Infrastructure Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIP#NASDAQ">FIP</a>) shares tumbled 12.4% to $7.04 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/01/42965686/top-2-industrials-stocks-that-may-fall-off-a-cliff-in-january">Top 2 Industrials Stocks That May Fall Off A Cliff In January</a></li>
</ul>

Why KB Home Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket

WIIM

Avinger shares are trading higher after the company announced it has been granted European patent number EP3322338 titled "MICRO-MOLDED ANAMORPHIC REFLECTOR LENS FOR IMAGE GUIDED THERAPEUTIC/DIAGNOSTIC CATHETERS".

<a href="https://register.epo.org/application?number=EP16825136" title="https://register.epo.org/application?number=EP16825136">https://register.epo.org/application?number=EP16825136</a>

Biotech

General

Avinger Has Been Granted European Patent Number EP3322338 Titled "MICRO-MOLDED ANAMORPHIC REFLECTOR LENS FOR IMAGE GUIDED THERAPEUTIC/DIAGNOSTIC CATHETERS".

Wall Street experienced a <a href="https://www.benzinga.com/news/treasuries/24/12/42674886/santa-rally-kicks-off-on-wall-street-stocks-gain-tesla-soars-bitcoin-hits-98000">positive start to the Santa Rally season</a>, with all major indices and sectors closing higher in a shortened session ahead of the Christmas holiday. The S&amp;P 500 climbed 1.1%, marking its third consecutive session of gains following last week&#8217;s volatile Federal Reserve meeting. Meanwhile, the tech-heavy Nasdaq 100 gained 1.35%, nearly erasing last week&#8217;s losses. The Dow Jones Industrial Average ended the session higher by 0.9%.
These are the top stocks that gained the attention of retail traders and investors throughout the day.
Tesla Inc. surged 7.35% to close at $462.25, reaching an intraday high of $462.78 and a low of $435.14. The stock has a 52-week high of $488.54 and a low of $138.80. CEO Elon Musk stated that Tesla could <a href="https://www.benzinga.com/24/12/42667044/teslas-valuation-could-exceed-all-transport-companies-but-spacex-ceo-elon-musk">surpass the value</a> of all transport companies except SpaceX, provided there is a lot of work and good ideas.
Avinger Inc. soared 125.72% to $1.45, with an intraday high of $1.93 and a low of $1.01. The stock&#8217;s 52-week high is $5.45, and the low is $0.39. The company said last week that it had <a href="https://www.benzinga.com/24/12/42666807/why-carbon-revolution-shares-are-trading-higher-by-around-62-here-are-20-stocks-moving-premarket">received a Notice of Allowance</a> for a U.S. patent titled "Catheter Device With Detachable Distal End (For The Treatment Of Peripheral Artery Disease)."
Jet.AI Inc. jumped 79.24% to $6.13, hitting an intraday high of $9.99 and a low of $5.85. The stock&#8217;s 52-week high is $607.51, with a low of $3.29. The company launched &#8220;Ava,&#8221; an advanced AI model designed to <a href="https://www.benzinga.com/news/small-cap/24/12/42674451/why-is-jet-ai-stock-trading-over-100-on-tuesday">streamline private jet bookings</a>, which significantly boosted its stock.
Teva Pharmaceutical Industries Limited saw a modest increase of 0.95% to $22.42, with an intraday high of $22.50 and a low of $22.19. The stock&#8217;s 52-week high is $22.50, and the low is $10.34. Stanley Druckenmiller&#8217;s Duquesne Family Office <a href="https://www.benzinga.com/24/12/42668157/stanley-druckenmiller-offloads-streets-hottest-ai-stocks-heres-what-the-billionaire-investor-is-loading-up-on">increased its stake</a> in Teva Pharmaceutical by acquiring over 1.4 million shares in the third quarter.
Netflix Inc. rose 2.27% to $932.12, reaching an intraday high of $935.85 and a low of $911.70. The stock&#8217;s 52-week high is $941.75, with a low of $461.86. Netflix recently <a href="https://www.benzinga.com/24/12/42675098/netflix-takes-vmware-to-court-over-patent-infringement-claims">filed a lawsuit</a> against Broadcom&#8217;s subsidiary VMware over patent infringement, which could impact future operations.
Prepare for the day&#8217;s trading&nbsp;<a href="https://editorial.benzinga.com/wp-admin/Premarket%20Movers%20&amp;%20News">with top premarket movers and news</a>&nbsp;by Benzinga.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42639340/bernie-sanders-is-all-for-canada-becoming-the-51st-state-if-the-u-s-will-also-adopt-universal-healthcare?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bernie Sanders Is &#8216;All For&#8217; Canada Becoming The 51st State If The U.S. Will Also Adopt Universal Healthcare</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Equities

JTAI

NFLX

TEVA

TSLA

Tesla, Avinger, Jet.Ai, Teva, And Netflix: Why These 5 Stocks Are On Investors' Radars Ahead Of Christmas

<h3>Gainers</h3>
<ul>
<li>Avinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) stock increased by 169.3% to $1.73 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.5 million. </li>
<li>Carmell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTCX#NASDAQ">CTCX</a>) stock moved upwards by 85.32% to $0.42. The company's market cap stands at $8.7 million. </li>
<li>Tivic Health Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) stock rose 69.47% to $0.38. The market value of their outstanding shares is at $3.1 million. </li>
<li>NeueHealth (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEUE#NYSE">NEUE</a>) shares rose 63.57% to $7.05. The market value of their outstanding shares is at $58.4 million. </li>
<li>180 Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNF#NASDAQ">ATNF</a>) shares rose 39.03% to $2.6. The company's market cap stands at $5.1 million. </li>
<li>Theriva Biologics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TOVX#AMEX">TOVX</a>) shares increased by 23.07% to $1.6. The market value of their outstanding shares is at $4.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>KalVista Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALV#NASDAQ">KALV</a>) stock fell 20.7% to $7.0 during Tuesday's pre-market session. The company's market cap stands at $345.9 million. </li>
<li>Anebulo Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANEB#NASDAQ">ANEB</a>) shares declined by 16.0% to $1.05. The market value of their outstanding shares is at $27.2 million. </li>
<li>Dogwood Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DWTX#NASDAQ">DWTX</a>) stock declined by 13.61% to $2.35. The company's market cap stands at $3.1 million. </li>
<li>Traws Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRAW#NASDAQ">TRAW</a>) stock fell 12.1% to $11.05. The market value of their outstanding shares is at $33.4 million. </li>
<li>Astria Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXS#NASDAQ">ATXS</a>) stock fell 11.77% to $8.4. The market value of their outstanding shares is at $474.0 million. </li>
<li>Ocean Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCEA#NASDAQ">OCEA</a>) stock fell 11.74% to $0.56. The company's market cap stands at $19.6 million. The company's, Q2 earnings came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ANEB

ATNF

ATXS

CTCX

DWTX

KALV

OCEA

TRAW

Avinger Shares Halted On Circuit Breaker To The Upside, Stock Now Up 197.3%

Avinger Shares Resume Trading

<a href="https://ppubs.uspto.gov/dirsearch-public/print/downloadBasicPdf/12171407?requestToken=eyJzdWIiOiI5ZDUzYjAzYi03YmNjLTRhZDQtOTI2Zi00MjUzYzIwY2ZkNDYiLCJ2ZXIiOiI2MDMxNmVkZi00ZWIzLTRlMzQtOWRlMS1jNGNlYjhiNmM3ZDEiLCJleHAiOjB9" title="https://ppubs.uspto.gov/dirsearch-public/print/downloadBasicPdf/12171407?requestToken=eyJzdWIiOiI5ZDUzYjAzYi03YmNjLTRhZDQtOTI2Zi00MjUzYzIwY2ZkNDYiLCJ2ZXIiOiI2MDMxNmVkZi00ZWIzLTRlMzQtOWRlMS1jNGNlYjhiNmM3ZDEiLCJleHAiOjB9">https://ppubs.uspto.gov/dirsearch-public/print/downloadBasicPdf/12171407?requestToken=eyJzdWIiOiI5ZDUzYjAzYi03YmNjLTRhZDQtOTI2Zi00MjUzYzIwY2ZkNDYiLCJ2ZXIiOiI2MDMxNmVkZi00ZWIzLTRlMzQtOWRlMS1jNGNlYjhiNmM3ZDEiLCJleHAiOjB9</a>

Avinger Awarded U.S. Patent 'US 12171407 B2' For 'ATHERECTOMY CATHETER DRIVE ASSEMBLIES'

Avinger Shares Halted On Circuit Breaker To The Upside, Stock Now Up 164.6%

Avinger Shares Resume Trade

Avinger Shares Halted On Circuit Breaker To The Upside, Stock Now Up 128.8%

U.S. stock futures advanced on Tuesday, ahead of a shortened trading session owning to Christmas Eve. The stock market will shut at 1 p.m. ET, while the bond market closes at 2:00 p.m. ET on Tuesday, whereas both the markets will remain closed for Christmas on Dec. 25. Futures of all four major indices advanced.
The S&amp;P 500 index is on its way to registering a robust 20% plus return for the second consecutive year in 2024, as most analysts expect a &#8220;Santa Rally&#8221; during this time of the year.
The 10-year and two-year Treasury notes yielded 4.59% and 4.34%, respectively. The probability of having no change in the interest rates for the upcoming Jan. 31, 2025 decision was at 91.4%, according <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">to</a> CME Group&#8217;s FedWatch tool.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.19%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.12%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.02%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.02%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Tuesday, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was up 0.16% to $595.67 and the Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rose 0.24% to $524.10, according to <a href="https://pro.benzinga.com/dashboard">Benzinga</a> Pro data.
Cues From The Last Session
U.S. stocks rebounded on <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42666701/nasdaq-gains-around-1-as-tesla-nvidia-rise-ahead-of-christmas-greed-index-remains-in-fear-zone">Monday</a>, with the tech-heavy Nasdaq leading the gains. The Nasdaq Composite surged 0.98%, buoyed by strong performances from Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and Nvidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
Economic data released on Monday showed mixed results. The Chicago Fed National Activity Index improved slightly, while U.S. durable goods orders unexpectedly declined.
Sector performance was varied. Communication services, healthcare, and information technology led the gains, while consumer staples and materials lagged. Last week, all major indices posted losses. The Dow Jones Industrial Average suffered its third consecutive losing week, declining by roughly 2.3%. The S&amp;P 500 and Nasdaq Composite also experienced declines, falling by approximately 2% and 1.8%, respectively. 
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.98%</td>
<td>19,764.89</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.73%</td>
<td>5,974.07</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.16%</td>
<td>42,906.95</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.22%</td>
<td>2,237.44</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
According to the chief market strategist at Carson Research, Ryan Detrick even though the last seven days of the previous year were negative, &#8220;The next 7 days are officially the Santa Claus Rally period.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The next 7 days are officially the Santa Claus Rally period. Down last year, but down back-to-back years only twice since 1950. <a href="https://t.co/S5czvrd6SY">pic.twitter.com/S5czvrd6SY</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1871296502536307092?ref_src=twsrc%5Etfw">December 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Detrick also added that no other seven-day period except the last seven days of the year is more likely to be higher. This period of &#8220;Santa Rally&#8221; has given positive returns at least 78.4% of the time.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">These next 7 trading days are known as the Santa Claus Rally period. There is no 7 day period more likely to be higher (78.4% of the time) and only two 7 day periods have a better avg return (1.29%). &#x1f385; <a href="https://t.co/40qVwHa1rS">pic.twitter.com/40qVwHa1rS</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1871322312219468049?ref_src=twsrc%5Etfw">December 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He also added that this year has seen only an 8.5% correction or peak-to-through pullback in August, however, on average a year sees a 14.2% correction, increasing the possibility of some correction in 2025.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">S&amp;P 500 up about 25% this year with only an 8.5% peak-to-through pullback all year (August). Just remember the avg year sees an 14.2% correction, which increases the odds it might happen next year. <a href="https://t.co/nV9i2yL9dU">pic.twitter.com/nV9i2yL9dU</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1871299031672205315?ref_src=twsrc%5Etfw">December 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
While the <a href="https://x.com/RyanDetrick/status/1871317802306707882">first</a> year of a new president&#8217;s term has usually been strong since 1897, the returns during the first year of a second term haven&#8217;t been very good overall, Detrick said.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Returns during year one of a second term haven&#39;t been very good overall, but way better lately. Down 5 in a row, but now up 4 in a row. &#x1f914; <a href="https://t.co/aUrCbf22Gw">pic.twitter.com/aUrCbf22Gw</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1871320275129967103?ref_src=twsrc%5Etfw">December 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Talking about the proposed policy changes by President-elect Donald Trump, Louis Navellier of Navellier &amp; Associates said, &#8220;On the table is all the uncertainty about the many changes that the new Trump administration has announced, both how quickly they will be implemented and what the ripple effects might be especially tariffs. The conflicts in the Mideast and Ukraine appear to be escalating. In the end, these many risks will only impact stocks if they impact earnings, and for now, estimates for &#8217;25 are holding.
&#8220;Optimistic analyst targets, stretched positioning and high valuations leave the market vulnerable to larger pullbacks in our view, should we see any of the rosy projections falling short of lofty expectations. This does not leave us underweight Equities. We acknowledge the power of bull markets mean there may still be room to run,&#8221; said Mario Georgiou, executive director, head of investments, at InCred Global Wealth.
See Also:&nbsp;<a href="https://www.benzinga.com/money/how-to-trade-futures">How To Trade Futures</a>
Upcoming Economic Data
A few important data points are slated to be released in this truncated week that will help investors determine the future course of action.
<ul>
<li>On Tuesday, November&#8217;s data for durable goods orders and durable goods minus transportation will be released at 8:30 a.m., ET.</li>
<li>New home sales for November will be released at 10:00 a.m. ET.</li>
<li>On Thursday, initial jobless claims data till Dec. 21 will announced at 8:30 a.m. ET.</li>
<li>On Friday, November&#8217;s data for the advanced U.S. trade balance in goods, advanced retail inventories, and advanced wholesale inventories will be announced at 8:30 a.m., ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Carbon Revolution PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CREV#NASDAQ">CREV</a>) was up 56.81% in premarket after it inked an agreement with OIC for a further $25 million in financing to support the ongoing liquidity of the business.</li>
<li>Avinger Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) was up 236.4%. Last week, the company announced it has received a Notice of Allowance for a U.S. patent titled "Catheter Device With Detachable Distal End (For The Treatment Of Peripheral Artery Disease)."</li>
<li>Tivic Health Systems Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) was up 68% after the company&#8217;s CEO outlined 2025 priorities, seeing a 30% reduction in net operating loss.</li>
<li>Neuehealth Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEUE#NYSE">NEUE</a>) gained 58.93% after it entered into a definitive merger to be acquired for $7.33 per share.</li>
<li>Theriva Biologics Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOVX#NYSE">TOVX</a>) rose 30% after it received a notice of allowance for a U.S. Patent titled "Microbiome Protection from Oral Antibiotics."</li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures were higher in the early New York session by 0.77% to hover around $69.77 per barrel.
The gold spot index was up by 0.11% to $2,631.19 per ounce. The Dollar Index was up 0.16% to 108.210 level.
Asian markets were mixed on Tuesday, as Hong Kong&#8217;s Hang Seng, China&#8217;s CSI 300 and Australia&#8217;s ASX 200 index rose. Whereas, South Korea&#8217;s Kospi, Japan&#8217;s Nikkei 225, and India&#8217;s S&amp;P BSE Sensex index declined. Most European markets traded higher.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42640560/japan-cannot-happen-here-was-common-refrain-20-years-ago-in-the-west-mohammed-el-erian-says-as-tokyo-climbs-out-of-the-hole-this-country-looks-at-risk-of-falling-in">Mohammed El Erian Says This Country Faces Japan-Style Economic Risk Even As Tokyo Rebounds</a></li>
</ul>
Photo courtesy: Wikimedia

Futures

Economics

Federal Reserve

ETFs

NVDA

US Stocks To Open Higher On Shortened Trading Day: Santa Claus Rally Period Officially Begins, Says Analyst

Shares of Carbon Revolution Public Limited Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CREV#NASDAQ">CREV</a>) rose sharply during Tuesday's pre-market session after the company announced it has reached an agreement with OIC for a further $25 million in financing to <a href="https://www.benzinga.com/quote/CREV">support the ongoing liquidity of the business.</a>
Carbon Revolution shares jumped 62.4% to $6.32 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Avinger, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) gained 138.2% to $1.53 in pre-market trading. Avinger, last week, announced it has received a Notice of Allowance for a U.S. patent titled &#8220;Catheter Device With Detachable Distal End (For The Treatment Of Peripheral Artery Disease).&#8221;</li>
<li>Tivic Health Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) gained 107% to $0.4650 in pre-market trading after the company's CEO outlined 2025 priorities, seeing a 30% reduction in net operating loss.</li>
<li>NeueHealth, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEUE#NYSE">NEUE</a>) gained 59.2% to $6.86 in pre-market trading after the company announced it has entered into a definitive merger to be acquired for $7.33 per share.</li>
<li>Theriva Biologics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOVX#NYSE">TOVX</a>) rose 38.5% to $1.80 in pre-market trading after the company announced it received a notice of allowance for U.S. Patent Application No. 18.534,962 titled &#8220;Microbiome Protection from Oral Antibiotics.&#8221;</li>
<li>SES AI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) shares jumped 37.3% to $0.7150 in pre-market trading.</li>
<li>SEALSQ Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAES#NASDAQ">LAES</a>) gained 35% to $6.61 in pre-market trading after jumping more than 78% on Monday.</li>
<li>Nocera, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCRA#NASDAQ">NCRA</a>) rose 32.1% to $1.22 in pre-market trading after gaining around 9% on Monday.</li>
<li>AmpliTech Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPG#NASDAQ">AMPG</a>) gained 26.3% to $3.12 in pre-market trading after surging around 25% on Monday.</li>
<li>Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) rose 17.5% to $1.68 in pre-market trading after gaining over 13% on Monday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Sol-Gel Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLGL#NASDAQ">SLGL</a>) shares tumbled 42.2% to $0.9540 in pre-market trading after jumping 285% on Monday.</li>
<li>Check-Cap Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHEK#NASDAQ">CHEK</a>) declined 18.7% to $1.83 in pre-market trading after jumping around 270% on Monday.</li>
<li>KORE Group Holdings, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KORE#NYSE">KORE</a>) fell 15% to $1.25 in pre-market trading. KORE announced NYSE acceptance of plan to regain listing compliance.</li>
<li>Nvni Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVNI#NASDAQ">NVNI</a>) fell 12.8% to $4.97 in today's pre-market trading after dipping around 34% on Monday.</li>
<li>Fifth District Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDSB#NASDAQ">FDSB</a>) shares dipped 12.6% to $11.00 in pre-market trading after falling 3% on Monday.</li>
<li>Tutor Perini Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPC#NYSE">TPC</a>) dipped 12.1% to $22.01 in pre-market trading.</li>
<li>Reliance Global Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELI#NASDAQ">RELI</a>) shares fell 11.6% to $2.75 in pre-market trading after jumping 159% on Monday.</li>
<li>Helius Medical Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) fell 6.8% to $0.8950 in pre-market trading after gaining over 5% on Monday.</li>
<li>Lindblad Expeditions Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIND#NASDAQ">LIND</a>) shares fell 9.8% to $11.01 in pre-market trading.</li>
<li>Brookfield Infrastructure Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIPC#NYSE">BIPC</a>) fell 8.7% to $35.01 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42648003/how-to-earn-500-a-month-from-qualcomm-stock-2">How To Earn $500 A Month From Qualcomm Stock</a></li>
</ul>

Why Carbon Revolution Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket

Avinger shares are trading higher after the company announced it has received a Notice of Allowance for a U.S. patent titled "Catheter Device With Detachable Distal End (For The Treatment Of Peripheral Artery Disease)."

<a href="https://patentcenter.uspto.gov/applications/17747715/ifw/docs" title="https://patentcenter.uspto.gov/applications/17747715/ifw/docs">https://patentcenter.uspto.gov/applications/17747715/ifw/docs</a>

Avinger Has Received A Notice Of Allowance For A U.S. Patent Titled "CATHETER DEVICE WITH DETACHABLE DISTAL END (FOR THE TREATMENT OF PERIPHERAL ARTERY DISEASE)".

<h3>Gainers</h3>
<ul>
<li>Palisade Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALI#NASDAQ">PALI</a>) shares rose 104.3% to $2.86 during Thursday's pre-market session. The company's market cap stands at $4.3 million. </li>
<li>Trevi Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVI#NASDAQ">TRVI</a>) stock rose 57.02% to $3.91. The market value of their outstanding shares is at $300.5 million. </li>
<li>Conduit Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) stock rose 21.97% to $0.11. The company's market cap stands at $12.5 million. </li>
<li>Gossamer Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOSS#NASDAQ">GOSS</a>) stock moved upwards by 17.16% to $0.83. The market value of their outstanding shares is at $189.1 million. </li>
<li>Jupiter Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUNS#NASDAQ">JUNS</a>) shares increased by 16.52% to $13.4. The company's market cap stands at $440.5 million. </li>
<li>Aptevo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) shares moved upwards by 15.5% to $11.56. The market value of their outstanding shares is at $5.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Keros Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KROS#NASDAQ">KROS</a>) shares fell 72.9% to $18.6 during Thursday's pre-market session. The market value of their outstanding shares is at $753.4 million. </li>
<li>Avinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) stock decreased by 46.35% to $0.44. The company's market cap stands at $1.4 million. </li>
<li>TFF Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TFFP#NASDAQ">TFFP</a>) stock declined by 45.98% to $0.09. </li>
<li>SHL Telemedicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLT#NASDAQ">SHLT</a>) shares declined by 21.35% to $2.69. The company's market cap stands at $44.0 million. </li>
<li>Telix Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLX#NASDAQ">TLX</a>) shares declined by 17.57% to $13.0. The company's market cap stands at $4.3 billion. </li>
<li>Evaxion Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVAX#NASDAQ">EVAX</a>) stock fell 10.77% to $1.16. The market value of their outstanding shares is at $6.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APVO

EVAX

GOSS

JUNS

KROS

PALI

SHLT

TFFP

TRVI

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Shares of DBV Technologies S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBVT#NASDAQ">DBVT</a>) rose sharply in the pre-market trading after the company announced alignment with the FDA on an accelerated approval pathway for the Viaskin peanut patch in toddlers <a href="https://www.benzinga.com/quote/DBVT">one to three years old</a>.
DBV Technologies shares jumped 36.9% to $4.60 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Palisade Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALI#NASDAQ">PALI</a>) gained 125% to $3.15 in pre-market trading.</li>
<li>AmpliTech Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPG#NASDAQ">AMPG</a>) gained 38.3% to $2.67 in pre-market trading after the company priced its $2.2 million registered direct offering of 1.35 million shares at $1.60 per share.</li>
<li>Wheeler Real Estate Investment Trust, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WHLR#NASDAQ">WHLR</a>) gained 35.2% to $6.05 in pre-market trading after dipping 16% on Wednesday.</li>
<li>Nuburu, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BURU#NASDAQ">BURU</a>) gained 27.5% to $0.3162 in pre-market trading after the company addressed NYSE compliance violations over 4.6 million share issuance.</li>
<li>Coeptis Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COEP#NASDAQ">COEP</a>) gained 19.2% to $0.22 in pre-market trading after gaining around 4% on Wednesday.</li>
<li>SRM Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRM#NASDAQ">SRM</a>) rose 15.8% to $0.8599 in pre-market trading after falling 6% on Wednesday.</li>
<li>Rezolve AI Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLV#NASDAQ">RZLV</a>) gained 12.5% to $2.24 in pre-market trading after gaining over 3% on Wednesday.</li>
<li>Charles &amp; Colvard, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTHR#NASDAQ">CTHR</a>) climbed 12% to $1.78 in pre-market trading after the company announced it received an interim award in Wolfspeed arbitration which led to reduced damages.</li>
<li>Absci Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>) gained 10.5% to $4.84 in pre-market trading following a 9% gain on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Avinger, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) shares tumbled 50% to $0.4200 in pre-market trading.</li>
<li>Sacks Parente Golf, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPGC#NASDAQ">SPGC</a>) declined 43.3% to $0.7938 in pre-market trading after declining 7% on Wednesday.</li>
<li>BriaCell Therapeutics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCTX#NASDAQ">BCTX</a>) shares fell 33.4% to $0.7310 in pre-market trading after the company announced the pricing of $5.5 million public offering.</li>
<li>Samfine Creation Holdings Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFHG#NASDAQ">SFHG</a>) fell 20.8% to $2.42 in pre-market trading after dipping 85% on Wednesday.</li>
<li>Primis Financial Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRST#NASDAQ">FRST</a>) dipped 20.1% to $10.01 in pre-market trading.</li>
<li>TFF Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TFFP#NASDAQ">TFFP</a>) shares fell 15.2% to $0.1379 in pre-market trading after dipping 46% on Wednesday.</li>
<li>NewGenIvf Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) fell 14% to $0.3103 in pre-market trading. The company recently announced it entered a binding term sheet regarding the proposed reverse merger with Wellness Investment.</li>
<li>New Era Helium, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEHC#NASDAQ">NEHC</a>) shares dipped 13.5% to $4.50 in pre-market trading after declining 9% on Wednesday.</li>
<li>Contineum Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTNM#NASDAQ">CTNM</a>) fell 12.3% to $12.50 in pre-market trading.</li>
<li>Adobe Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) fell 10% to $495.00 in today's pre-market trading. Adobe posted better-than-expected earnings and sales results for its fourth quarter. The company said it expects first-quarter revenue to be in the range of $5.63 billion to $5.68 billion versus estimates of $5.73 billion. The company anticipates first-quarter adjusted earnings of $4.95 to $5 per share versus estimates of $4.95 per share.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42437595/jim-cramer-says-keep-owning-this-energy-stock-abbott-laboratories-legal-stuff-is-behind-them">Jim Cramer Says &#8216;Keep Owning&#8217; This Energy Stock, Abbott Laboratories &#8216;Legal Stuff&#8217; Is Behind Them</a></li>
</ul>

ABSI

ADBE

BCTX

BURU

COEP

CTHR

CTNM

DBVT

FRST

NEHC

NIVF

RZLV

SFHG

SPGC

WHLR

Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket

Avinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) reported quarterly losses of $(1.82) per share which beat the analyst consensus estimate of $(2.03) by 10.34 percent. The company reported quarterly sales of $1.650 million which beat the analyst consensus estimate of $1.635 million by 0.92 percent. This is a 9.19 percent decrease over sales of $1.817 million the same period last year.

Earnings

Earnings Beats

Avinger Q3 2024 GAAP EPS $(1.82) Beats $(2.03) Estimate, Sales $1.650M Beat $1.635M Estimate

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Doximity (DOCS – Research Report), Avinger (AVGR –...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Doximity (DOCS), Avinger (AVGR) and GlycoMimetics (GLYC)

Avinger, Inc. (AVGR) Q2 2024 Earnings Call Transcript

Avinger stock gains on issuance of new U.S. patent

Avinger (AVGR) hosted a physician-focused webinar entitled, "New Approaches to Treating Peripheral Artery Disease Below-the-Knee and Promising New ...

Avinger releases updated data from IMAGE-BTK study in webinar

Avinger Q3 Earnings Preview

Avinger GAAP EPS of -$1.82 beats by $0.21, revenue of $1.7M beats by $0.06M

Avinger, Inc. (AVGR) Q3 2024 Earnings Call Transcript

Avinger ( ($AVGR) ) just unveiled an update. On December 11, 2024, Avinger announced that its named executive officers, Jeffrey M. Soinski, Himansh...

Avinger Executives Waive Rights Amid Liquidation Plans

Avinger ( ($AVGR) ) just unveiled an announcement. Avinger, Inc. held its 2024 Annual Meeting of Stockholders where the Third Amended and Restated ...

Avinger's 2024 Stockholder Meeting and Director Elections

Graphjet Technology, Avinger, and Snow Lake Resources are the 3&nbsp;Penny Stocks&nbsp;to watch on December 27, 2024, based on&nbsp;TipRanks' Penny...

3 Penny Stocks to Watch Now, 12/27/24

DOCS

GLYC

LITM

Legal

Press Releases

Avinger Announces Pricing of up to $24 Million Public Offering

Avinger Announces Closing of up to $24 Million Public Offering

Avinger to Announce Second Quarter 2024 Results on August 8, 2024

Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer

Avinger Reports Second Quarter 2024 Results

Avinger Initiates Full Commercial Launch of Pantheris LV Image-Guided Atherectomy Device

Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents

Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention

Comments

Avinger

Avinger (AVGR) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL